AIM: To explore the new target genes transactivated by hepatitis C virus (HCV) core protein and to elucidate the pathogenesis of HCV infection. METHODS: Reverse transcribed cDNA was subjected to microarray assay. The coding gene transactivated by HCV core protein was cloned and analyzed with bioinformatics methods. RESULTS: The expressive vector of pcDNA3.1(-)-core was constructed and confirmed by restriction enzyme digestion and DNA sequencing and approved correct. mRNA was purified from HepG2 and HepG2 cells transfected with pcDNA3.1(-)-core, respectively. The cDNA derived was subjected to microarray assay. A new gene named HCTP4 was cloned with molecular biological method in combination with bioinformatics method. CONCLUSION: HCV core is a potential transactivator. Microarray is an efficient and convenient method for analysis of differentially expressed genes.
AIM: To explore the new target genes transactivated by hepatitis C virus (HCV) core protein and to elucidate the pathogenesis of HCV infection. METHODS: Reverse transcribed cDNA was subjected to microarray assay. The coding gene transactivated by HCV core protein was cloned and analyzed with bioinformatics methods. RESULTS: The expressive vector of pcDNA3.1(-)-core was constructed and confirmed by restriction enzyme digestion and DNA sequencing and approved correct. mRNA was purified from HepG2 and HepG2 cells transfected with pcDNA3.1(-)-core, respectively. The cDNA derived was subjected to microarray assay. A new gene named HCTP4 was cloned with molecular biological method in combination with bioinformatics method. CONCLUSION:HCV core is a potential transactivator. Microarray is an efficient and convenient method for analysis of differentially expressed genes.
Authors: Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler Journal: Am J Gastroenterol Date: 2003-09 Impact factor: 10.864
Authors: Sandra Lechner; Ulf Müller-Ladner; Elena Neumann; Tanja Spöttl; Klaus Schlottmann; Josef Rüschoff; Jürgen Schölmerich; Frank Kullmann Journal: Lab Invest Date: 2003-09 Impact factor: 5.662
Authors: K Stephen Suh; Mariam Malik; Anjali Shukla; Andrew Ryscavage; Lisa Wright; Kasey Jividen; John M Crutchley; Rebecca A Dumont; Ester Fernandez-Salas; Joshua D Webster; R Mark Simpson; Stuart H Yuspa Journal: Carcinogenesis Date: 2012-03-01 Impact factor: 4.944
Authors: Sonja M Kessler; Stephan Laggai; Elien Van Wonterg; Katja Gemperlein; Rolf Müller; Johannes Haybaeck; Roosmarijn E Vandenbroucke; Manfred Ogris; Claude Libert; Alexandra K Kiemer Journal: Front Physiol Date: 2016-04-25 Impact factor: 4.566